Fanni Gergely elected to EMBO Membership
Dr Fanni Gergely, Senior Group Leader at the Institute, has been elected as a member of the European Molecular Biology Organisation (EMBO) in recognition of her high quality life science research.
Fanni is one of 56 new members who are joining more than 1800 of the best researchers in Europe and around the world.
Election to EMBO Membership is recognition of research excellence and the outstanding achievements made by a life scientist. EMBO Members actively participate in the execution of the organisation’s initiatives by serving on Council, committees and editorial boards, and by evaluating applications for EMBO funding. As a result, EMBO Members collectively influence the future directions of life science research and strengthen research communities across Europe.
It is an honour to be elected a member of EMBO. This award also recognises the research efforts of my talented team and fantastic collaborators
Dr Fanni Gergely, Cancer Research UK Cambridge Institute
Fanni’s research seeks to understand how centrosomes contribute to normal and pathological processes such as embryonic growth, neurodevelopment and tumourigenesis. By using a combination of genetic, molecular and proteomic tools, her team interrogates the roles of centrosome components in cell proliferation and signalling. Most recently, the group’s work is focused on identifying tissue-specific functions for these ubiquitous organelles.
“It is an honour to be elected a member of EMBO by my peers. This award also recognises the research efforts of my talented team and fantastic collaborators, all made possible by the invaluable support of Cancer Research UK and the Cambridge Institute” says Fanni. “I look forward to contributing to EMBO’s valuable work strengthening the research community in Europe and beyond.”
EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines
Maria Leptin, EMBO Director
“EMBO Members are excellent scientists who conduct research at the forefront of all life science disciplines, ranging from computational models or analyses of single molecules and cellular mechanics to the study of higher-order systems in development, cognitive neuroscience and evolution,” says EMBO Director Maria Leptin.
The new EMBO Members and Associate Members will be formally welcomed at the annual Members’ Meeting in Heidelberg between 29 and 31 October 2019.
Read more
Cambridge scientists recognised by major European research organisation
Related News
See all news-
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more -
Hot flush treatment has anti-breast cancer activity, study finds
5th January 2026
A drug mimicking the hormone progesterone has anti-cancer activity when used together with conventional anti-oestrogen treatment for women with breast cancer, a new Cambridge-led trial has found.
Find out more